Join Sensus Healthcare at the AAD Annual Meeting at the Boston Convention & Exhibition Center! We will be located in booth #4063.
Registration is Now Open. Register Here Today!
& Exhibition Center!
|
|
|
To our valued customers,
We wanted to share this editorial entitled, "COVID-19: Spirliang of Frailty in Older Italian Patients" written by A.M. Abbatecola and R. Antonelli-Incalzi. In this article it is highlighted that "due to the rapid spread of the coronavirus in Italy, there seems to be a deadly trend toward mortality with COVID-19 in older patients with specific comorbidities, thus identifying a new “COVID Spiraling Frailty Syndrome”." Available data from the ISS show that the most common commorbidities observed in all Italians dying with COVID-19 are "arterial hypertension (74.7%) and Type 2 Diabetes (30.5%)". Please read the full article to learn more. We can all get through this together!
Skin cancer can be broadly split in to two types: melanoma and non-melanoma. The most common non-melanomas include basal cell carcinoma and squamous cell carcinoma, for which the main treatment is surgery. However, other non-surgical options are emerging, including superficial radiation therapy (SRT), a unique type of photon radiotherapy.
To learn more about SRT we recently spoke with Joe Sardano, CEO at Sensus Healthcare. Joe explains what SRT is, how it works, and the cancers it is particularly suited to treating.
Read the full article here.
As a part of my series about “The Future of Healthcare” I had the pleasure of interviewing Joseph C. Sardano, Chief Executive Officer, Sensus Healthcare Inc. A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new technologies and services in many areas, including electronic brachytherapy, PET and PET/CT, SPECT, MRI, lithotripsy and digital radiography. Before joining Sensus Healthcare, Sardano held leadership and management roles at CTI Molecular Imaging, GE Medical Systems, Siemens Medical Systems, Elscint Inc and Toshiba America Medical Systems, among others.
Read the full article here.
Researchers found in a retrospective study of 297 surgically excised keloids with superficial radiation therapy around the excision site that only 3% recurred during an average 6-month follow-up.
Read the full article here.
Dr. Kenrick Spence, a Central Florida doctor, discusses the benefits of the SRT-100+ for keloid removal at Hilcrest Plastic Surgery in Orlando. With over 18 million people suffering from keloids, the market to remove the painful and itchy overgrowths of scars is highly in demand in this community.
Read the full article here.
Dr. Kristine A. Romine, MD, CEO and Founder of Camelback Dermatology & Skin Surgery in Phoenix, AZ, explains the difference the personalized approach to skin cancer treatment that SRT provides to skin cancer patients.
Read the full article here.
Superficial Radiation Therapy and our CEO, Joe Sardano, are making headlines with Dermatology Times. This article highlights the benefits of using SRT alongside Mohs surgery when treating skin cancer patients. With 80 percent of skin cancers appearing on the face and neck, a less invasive approach is very sought out by sufferers.
Read the full article here.
Over the past several years, Mr. Sardano, CEO of Sensus Healthcare, has worked tirelessly to offer a non-surgical solution for non-melanoma skin cancer and an effective treatment for keloid scars. The state-of-the-art Superficial Radiation Therapy (SRT) technology is the non-surgical treatment option dermatologists and oncologists have been waiting for. Upon receiving the "Non-Physician Non-Surgical Innovator of the Year" award at the 2018 Aesthetic Awards, Mr. Sardano remarked, “We are absolutely thrilled, surprised and excited to be recognized. We take the award seriously. We will work hard to live up to the expectations that have been set, and continue to provide world-class technology that works well within the physician’s environment.”It is crucial for dermatologists to be at the frontline of the skin cancer epidemic. Jeffrey S. Fromowitz, MD, FAAD, understands the difficulty educating patients and providing physicians with the different skin cancer treatments that currently are available. Surgery is typically coupled with downtime and invasive procedures. Since many skin cancer treatment recipients are seniors, the invasive route is often not an option. Dr. Fromowitz explains the pros and cons of the different skin cancer treatments in this article.
Dr. Kevin Schewe the Radiation Oncologist and Medical Director at Alliance Cancer Care at Red Rocks discusses the dangers of UV rays, the different types of skin cancer and SRT with Colorado's Best on FOX network Channel 2 and Channel 31 in Denver.
Watch the video here.
Lisa Pace has had 86 skin cancer surgeries and she's only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses the importance of sun-protection and the dangers of tanning beds. She adds: “I want people to realize that it can happen to anybody. I’m adamant about young people knowing this before it’s too late.”
Read the full article here.
In this week's CEO Money segment Michael Yorba sits down with Dallas dermatologist, Dr. Ellen Turner to learn about skin cancer, and why her practice is using Superficial Radiation Therapy (SRT) — a new, non-surgical skin cancer treatment option that has a remarkable cure rate.
Read the full article and listen to the interview here.
City & Shore Magazine recently wrote an article regarding the alternative treatment options to skin cancer surgery. Dr. Jason Green, DO and SRT was featured in the article. Check out the full article here.
Achieving complete keloid scar removal is extremely difficult. The SRT-100 is the only FDA cleared treatment after keloid removal option on the market. Recently the machine was featured in an article on Practical Dermatology's website.
Read the full article here.
Read more blogs and news here.